John SimboliUnclaimed
Host of BioBoss.
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
PodCred record
PodCred is the verified record of where John has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with John on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when John claims this profile.
Recommendations
John has not written any yet.
Recommendations open once John claims the profile.
Posts
No posts yet. Posts John shares on PodSubs, and what John publishes on Substack, YouTube and elsewhere, will show here.
Recent episodes
From the shows they work on now
Stephan Jackman: CEO of Alzamend Neuro
Stephan Jackman, CEO of Alzamend Neuro, shares his insights about leadership in biopharma and how Alzamend is working to develop effective treatments for psychiatric disorders.
Ryan Beal: Co-Founder and CEO of Dyve Biosciences
Ryan Beal, CEO of Dyve Biosciences, shares his insights about leadership in biopharma and how Dyve is working to deliver targeted pH modulation to treat a range of immunologic and oncologic diseases.
Haseeb Ahmad - CEO of Purespring Therapeutics
Haseeb Ahmad, CEO of Purespring Therapeutics, shares his insights about leadership in biopharma and how Purespring is working to help patients with kidney diseases to live fuller, healthier lives.
Lance Baldo: CEO of Beacon Therapeutics
Lance Baldo, CEO of Beacon Therapeutics, shares his insights about leadership in biopharma and how Beacon is working to save and restore sight for people living with rare and prevalent ocular diseases.
Shaun Bagai: CEO of RenovoRX
Shaun Bagai, CEO of RenovoRX, shares his insights about leadership in biopharma and how RenovoRX is working to develop targeted oncology therapies and commercialize its FDA cleared drug delivery device.
Hyung Heon Kim: CEO of MetaVia
Hyung Heon Kim, CEO of MetaVia, shares his insights about leadership in biopharma and how MetaVia is working to transform cardiometabolic disease.
David Southwell: CEO of Volastra Therapeutics
David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a...
Stacy Lindborg: CEO of Imunon
Stacy Lindborg, CEO of Imunon, shares her insights about leadership in biopharma and how Imunon is working to develop medicines that harness the building blocks of life to work in harmony with the body's immune system.
Welcome to Season 8 of BioBoss
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026
Michael Cloonan: CEO of Sionna Therapeutics
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic...
